COMPARATIVE-STUDIES ON FUNCTIONAL AND SECRETORY PROPERTIES OF MACROPHAGE CELL-LINES DERIVED FROM DIFFERENT ANATOMICAL SITES

被引:12
|
作者
BLASI, E [1 ]
PULITI, M [1 ]
PITZURRA, L [1 ]
BARLUZZI, R [1 ]
MAZZOLLA, R [1 ]
ADAMI, C [1 ]
COX, GW [1 ]
BISTONI, F [1 ]
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,MACROPHAGE CELL BIOL LAB,FREDERICK,MD
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 1994年 / 9卷 / 03期
关键词
MACROPHAGE; CYTOKINE; FUNCTIONAL HETEROGENEITY;
D O I
10.1111/j.1574-695X.1994.tb00495.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we compared four macrophage (M phi) cell lines from different anatomical origins for functional and secretory activities against the two morphogenetic forms of the fungus Candida albicans. We show that all the cell lines actively phagocytize the yeast and exert antimicrobial activity against both forms of Candida, although M phi of microglial origin are the most effective. When assessed for secretory properties, microglial M phi exhibit a peculiar pattern with respect to other M phi populations under either basal or stimulated conditions. In particular, only microglial M phi fail to respond to the hyphal form of the fungus (H-Candida), which instead acts as a potent tumor necrosis factor inducer in the other M phi cell lines. When exposed to H-Candida, microglial M phi are indistinguishable from other M phi in their ability to modulate specific surface adhesion molecules. In addition to strengthening the knowledge on functional heterogeneity among M phi, our data provide evidence on the peculiar behavior of microglial M phi. To what extent M phi heterogeneity may be related to tissue homeostasis is discussed.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 50 条
  • [21] Functional diversity of cardiomyocytes derived from different embryonic stem cell lines
    Halbach, M.
    Hannes, T.
    Khalil, M.
    Wolff, M.
    Pfannkuche, K.
    Pillekamp, F.
    Sachinidis, A.
    Brockmeier, K.
    Muller-Ehmsen, J.
    Hescheler, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 322 - 322
  • [22] SUPPRESSION OF TUMORIGENICITY IN HUMAN CELL HYBRIDS DERIVED FROM CELL-LINES EXPRESSING DIFFERENT ACTIVATED RAS ONCOGENES
    GEISER, AG
    ANDERSON, MJ
    STANBRIDGE, EJ
    CANCER RESEARCH, 1989, 49 (06) : 1572 - 1577
  • [23] COMPARATIVE STUDIES ON CELL-LINES ESTABLISHED FROM NORMAL AND RADIATION-EXPOSED MINIATURE SWINE
    FRAZIER, ME
    USHIJIMA, RN
    ANDREWS, TK
    HOOPER, MJ
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1979, 15 (12): : 1001 - 1012
  • [24] PRODUCTION OF MONOCYTE MACROPHAGE COLONY-STIMULATING FACTOR BY PREADIPOCYTE CELL-LINES DERIVED FROM MURINE MARROW STROMA
    LANOTTE, M
    METCALF, D
    DEXTER, TM
    JOURNAL OF CELLULAR PHYSIOLOGY, 1982, 112 (01) : 123 - 127
  • [25] SPECIFICITY OF NATURAL CYTO-TOXICITY AGAINST CELL-LINES DERIVED FROM DIFFERENT GENITOURINARY TUMORS
    SCHMITZDRAGER, BJ
    HAYAKAWA, M
    ACKERMANN, R
    PROSTATE, 1982, 3 (03): : 318 - 318
  • [26] IDENTITY AND FUNCTIONAL-PROPERTIES OF NOVEL SKIN-DERIVED FIBROBLAST LINES (NS SERIES) THAT SUPPORT THE GROWTH OF EPIDERMAL-DERIVED DENDRITIC CELL-LINES
    SCHUHMACHERS, G
    XU, S
    BERGSTRESSER, PR
    TAKASHIMA, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) : 225 - 230
  • [27] MORPHOLOGICAL-STUDIES ON NEOPLASMS DERIVED FROM TRANSPLANTATION OF LONG-TERM CJD CELL-LINES
    KIM, JH
    MANUELIDIS, L
    MANUELIDIS, EE
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1990, 49 (03): : 312 - 312
  • [28] COMPARATIVE-STUDIES ON THE POLYAMINE METABOLISM AND DFMO TREATMENT OF MCF-7 AND MDA-MB-231 BREAST-CANCER CELL-LINES AND XENOGRAFTS
    KREMMER, T
    PALYI, I
    DAUBNER, D
    BOLDIZSAR, M
    VINCZE, B
    PAULIK, E
    SUGAR, J
    POKORNY, E
    TURY, E
    ANTICANCER RESEARCH, 1991, 11 (05) : 1807 - 1813
  • [29] PROPERTIES OF BONE-MARROW STROMAL CELLS AND DERIVED CELL-LINES FROM SJL/J MICE
    ZIPORI, D
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 10 - 10
  • [30] HETEROGENIC PROPERTIES OF CLONAL CELL-LINES DERIVED FROM CANINE MAMMARY CARCINOMAS AND SENSITIVITY TO TAMOXIFEN AND DOXORUBICIN
    SARTIN, EA
    BARNES, S
    TOIVIOKINNUCAN, M
    WRIGHT, JC
    WOLFE, LG
    ANTICANCER RESEARCH, 1993, 13 (01) : 229 - 236